Experimental Brain Research · Oct 26, 2026
Analysis of Urolithin A's regulation of microglial inflammation and autophagy in herpes simplex encephalitis via modulating the PI3K/AKT signaling pathway through network pharmacology
By Tan Z, Wang J, Xie J et al.
Herpes simplex encephalitis (HSE) is severe central nervous system inflammation triggered by herpes simplex virus type 1 (HSV-1). Urolithin A (UA), an intestinal flora-derived metabolite from dietary ellagitannins, possesses anti-inflammatory, antioxidant and autophagy-regulating properties, yet its regulatory function on microglia during HSE remains unclear. HSV-1-infected BV2 mouse microglia were used as an in vitro HSE model. CCK-8 was applied to detect cell viability; ELISA measured inflammatory cytokine secretion; qRT-PCR and flow cytometry assessed M1 microglial polarization; western blot tested autophagy-associated protein expression. Network pharmacology screened potential UA targets, and rescue assays validated the involvement of the PI3K/AKT pathway. UA exerted no obvious cytotoxicity against BV2 cells within 0-20 µM and restored viability of HSV-1-damaged BV2 cells. It reduced TNF-α, IL-6 and IFN-β release, downregulated M1 markers (iNOS, TNF-α) and CD86-positive cell proportion, and suppressed excessive autophagy via decreasing LC3-II/LC3-I ratio and elevating p62 expression. Network pharmacology identified Akt1 as the core target linked to the PI3K/AKT pathway. Rescue tests revealed that PI3K/AKT activation abolished UA's regulatory effects. In summary, UA alleviates HSV-1-induced microglial inflammatory injury by inhibiting PI3K/AKT overactivation, M1 polarization and abnormal autophagy.
doi.org/10.1007/s00221-026-07410-xPubMed 42931954Interventions